| 2022-03-23 | +44.2% | news | The Motley Fool | Why Alpha Tau Medical Ltd. Stock Soared 42% on Wednesday - The Motley Fool |
| 2022-07-05 | +38.4% | news | Seeking Alpha | Israeli medtech Alpha Tau stock rallies 31% after dropping 16% in prior session |
| 2022-03-10 | +31.0% | earnings | MarketBeat | Alpha Tau Medical (DRTS) Stock Price, News & Analysis $DRTS - MarketBeat |
| 2022-03-10 | +31.0% | earnings | MarketBeat | Alpha Tau Medical (DRTS) Earnings Date and Reports 2026 $DRTS - MarketBeat |
| 2025-12-09 | +29.5% | news | Stock Titan | Alpha Tau (Nasdaq: DRTS) gives first Alpha DaRT brain treatment in OSU GBM study - Stock Titan |
| 2022-05-26 | +26.8% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.54 |
| 2022-03-31 | -21.5% | news | TradingView | Number of employees of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView |
| 2022-03-11 | +20.8% | news | TradingView | Technical Analysis of Alpha Tau Medical Ltd. (NASDAQ:DRTS) - TradingView |
| 2022-04-04 | +20.6% | analyst | Seeking Alpha | Alpha Tau Medical gains as Citi initiates coverage with a Buy rating |
| 2026-01-05 | +19.6% | news | Stock Titan | New radiation implant edges closer for tough-to-treat skin cancer patients - Stock Titan |
| 2025-05-19 | +17.1% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.11 |
| 2022-03-22 | +16.9% | news | StockInvest.us | Alpha Tau Medical Stock Price Forecast. Should You Buy DRTS? - StockInvest.us |
| 2025-12-10 | +16.4% | analyst | Investing.com | H.C. Wainwright reiterates Buy rating on Alpha Tau Medical stock - Investing.com |
| 2022-09-02 | -16.3% | executive | Seeking Alpha | Alpha Tau director gives up board seat to take up chief commercial officer role |
| 2022-03-24 | +15.0% | news | TradingView | DRTS Stock Price and Chart — NASDAQ:DRTS - TradingView |
| 2023-04-24 | +14.8% | news | Seeking Alpha | Alpha Tau Medical a new buy at HC Wainwright on proprietary radiation therapy |
| 2026-02-24 | +13.6% | news | Stock Titan | Japan okays first-in-kind Alpha DaRT for hard-to-treat head and neck cancer - Stock Titan |
| 2026-02-24 | +13.6% | news | TipRanks | Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy - TipRanks |
| 2026-01-06 | +12.8% | analyst | Investing.com | Alpha Tau Medical stock advances as H.C. Wainwright reiterates Buy rating - Investing.com |
| 2026-01-06 | +12.8% | news | TipRanks | Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026 - TipRanks |
| 2022-11-28 | -12.4% | earnings | TradingView | Alpha Tau Medical Ltd. Earnings and Revenue – NASDAQ:DRTS - TradingView |
| 2022-04-08 | -9.1% | news | marketscreener.com | Alpha Tau Medical Ltd.: Shareholders Board Members Managers and Company Profile | IL0011839383 - marketscreener.com |
| 2022-03-28 | +9.1% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.67 |
| 2022-03-28 | +9.1% | legal | Stock Titan | Latest DRTS News - Alpha Tau Announces FDA Approval of IDE Sup... - Stock Titan |
| 2026-01-29 | -8.2% | news | Stock Titan | Cancer therapy Alpha DaRT advances in 5 U.S. trials with 2026 results ahead - Stock Titan |
| 2026-01-20 | -7.9% | news | Zacks Investment Research | Should I buy Alpha Tau Medical (DRTS) - Zacks Investment Research |
| 2025-05-08 | +7.9% | news | simplywall.st | Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention - simplywall.st |
| 2023-10-30 | +7.3% | legal | Seeking Alpha | Alpha Tau enters into long-term lease of site in New Hampshire for second U.S. manufacturing facility |
| 2026-01-17 | -7.2% | news | AD HOC NEWS | Alpha Tau Medical: Micro-cap radiotherapy stock tests investor patience as volatility picks up - AD HOC NEWS |
| 2026-02-25 | +7.0% | analyst | TipRanks | Alpha Tau price target raised to $12 from $9 at H.C. Wainwright |
| 2026-02-25 | +7.0% | news | Business Wire | HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT |
| 2022-11-22 | -6.9% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of $0.04 |
| 2026-03-05 | -6.8% | news | DirectorsTalk Interviews | Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Promising Potential With A 28.21% Upside - DirectorsTalk Interviews |
| 2026-03-09 | +6.0% | news | GlobeNewswire | Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update |
| 2026-03-09 | +6.0% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.42 |
| 2026-03-09 | +6.0% | news | GlobeNewswire | Alpha Tau Announces Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire |
| 2026-03-09 | +6.0% | news | TipRanks | Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year - TipRanks |
| 2022-04-12 | +5.5% | news | Seeking Alpha | Alpha Tau: Treating Cancer With Precision Alpha Radiation |
| 2022-04-12 | +5.5% | earnings | MarketBeat | Alpha Tau Medical (DRTS) Short Interest & Short Float | Updated Apr 2026 $DRTS - MarketBeat |
| 2025-08-11 | -5.0% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.22 |
| 2025-11-13 | -4.8% | news | DirectorsTalk Interviews | Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Promising 114% Potential Upside In Biotechnology - DirectorsTalk Interviews |
| 2024-05-20 | -4.6% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.11 |
| 2025-11-20 | +4.3% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.39 |
| 2026-01-27 | +3.3% | news | Yahoo Finance | New Strong Sell Stocks for January 27th - Yahoo Finance |
| 2025-10-23 | +3.3% | news | DirectorsTalk Interviews | Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 110% Potential Upside in Biotechnology - DirectorsTalk Interviews |
| 2025-10-16 | -3.0% | news | Seeking Alpha | Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology |
| 2025-10-16 | -3.0% | news | Seeking Alpha | Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology (NASDAQ:DRTS) - Seeking Alpha |
| 2023-08-28 | -3.0% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.24, revenue of $12.26M |
| 2026-03-16 | +2.9% | news | GlobeNewswire | Alpha Tau to Present at Sidoti March Virtual Small Cap Conference |
| 2026-03-16 | +2.9% | news | GlobeNewswire | Alpha Tau to Present at Sidoti March Virtual Small Cap Conference - GlobeNewswire |
| 2026-04-07 | +2.8% | earnings | MarketBeat | Alpha Tau Medical (NASDAQ:DRTS) Shares Up 5.2% - Here's What Happened - MarketBeat |
| 2023-08-18 | -2.4% | news | Seeking Alpha | Alpha Tau gains on data for radiation therapy |
| 2023-03-09 | +2.3% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.53 |
| 2024-05-11 | +2.3% | earnings | MarketBeat | Alpha Tau Medical (DRTS) Stock Forecast and Price Target 2026 $DRTS - MarketBeat |
| 2026-03-24 | -2.2% | news | Seeking Alpha | Alpha Tau Medical: 2026 Is The Breakthrough Year |
| 2026-03-24 | -2.2% | news | Seeking Alpha | Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha |
| 2022-06-08 | -2.0% | legal | Seeking Alpha | Alpha Tau rises 12% on FDA approval to begin trial of Alpha DaRT to treat skin cancer |
| 2025-04-28 | +2.0% | news | Seeking Alpha | Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical |
| 2026-03-31 | +2.0% | news | GlobeNewswire | Alpha Tau Announces First-Ever Oral Presentation of Alpha DaRT® Pancreatic Cancer Data at Digestive Disease Week (DDW) 2026 |
| 2026-03-31 | +2.0% | news | Stock Titan | Pancreatic cancer trial data from Jerusalem lands DDW podium slot - Stock Titan |
| 2026-03-31 | +2.0% | news | Stock Titan | Alpha Tau Medical (Nasdaq: DRTS) wins DDW 2026 oral slot for Alpha DaRT pancreatic cancer trials - Stock Titan |
| 2026-03-31 | +2.0% | news | TipRanks | Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data - TipRanks |
| 2026-04-02 | -1.9% | legal | Stock Titan | DRTS SEC Filings - Alpha Tau Medical Ltd 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-01-23 | +1.7% | news | Seeking Alpha | Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 |
| 2026-01-23 | +1.7% | news | Seeking Alpha | Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 - Seeking Alpha |
| 2023-05-23 | -1.7% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.12 misses by $0.01 |
| 2022-08-25 | -1.6% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.03 |
| 2022-08-25 | -1.6% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Alpha Tau Medical (DRTS) - Zacks Investment Research |
| 2024-04-06 | -1.4% | news | intelligentinvestor.com.au | Alpha Tau Medical Ltd (NASDAQ: DRTS) - Share Price - intelligentinvestor.com.au |
| 2023-11-16 | +1.4% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of $0.31 |
| 2026-03-19 | -1.3% | legal | MarketBeat | Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased |
| 2026-04-14 | +1.1% | news | TradingView | DRTS Options Chain — NASDAQ:DRTS - TradingView |
| 2026-04-14 | +1.1% | news | TradingView | DRTS Options Volatility — NASDAQ:DRTS - TradingView |
| 2022-10-11 | -1.0% | analyst | TradingView | DRTS Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-04-25 | -0.8% | news | Stock Titan | DRTS Stock Price, News & Analysis - Stock Titan |
| 2023-09-11 | -0.7% | news | Seeking Alpha | Alpha Tau Medical files to sell 1.1M ordinary shares for holders |
| 2025-12-11 | +0.6% | news | RTTNews | What's Next For Alpha Tau: Major Milestones Expected Through Early 2026 - RTTNews |
| 2024-03-07 | +0.6% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.42 |
| 2024-11-19 | -0.6% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.32 |
| 2026-03-04 | +0.6% | analyst | MT Newswires | Alpha Tau Medical Shares Fall After Piper Sandler Downgrade |
| 2026-03-04 | +0.6% | analyst | Investing.com South Africa | Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com South Africa |
| 2026-04-22 | +0.4% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | DRTS (Alpha Tau Medical Ltd. Ordinary Shares) posts narrower Q4 2025 loss than estimates, shares rise 0.75 percent today. - GDR - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-22 | +0.4% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Is Alpha Tau (DRTS) stock trading at a discount | Q4 2025: Profit Exceeds Views - Debt Refinancing - Cổng thông tin điện tử tỉnh Lào Cai |
| 2024-03-26 | +0.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-03-18 | -0.4% | news | Stock Titan | Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan |
| 2026-03-18 | -0.4% | executive | Stock Titan | Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan |
| 2026-03-18 | -0.4% | news | Stock Titan | Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan |
| 2026-03-18 | -0.4% | news | Stock Titan | Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan |
| 2026-03-18 | -0.4% | executive | Stock Titan | Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan |
| 2026-03-18 | -0.4% | news | Stock Titan | Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan |
| 2026-03-18 | -0.4% | news | Stock Titan | Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan |
| 2025-11-24 | -0.3% | analyst | GuruFocus | Alpha Tau Medical (DRTS) Receives Reiterated 'Buy' Rating from H - GuruFocus |
| 2025-06-23 | +0.3% | news | Seeking Alpha | Alpha Tau files to sell 3.46M ordinary shares by selling shareholders |
| 2024-03-08 | -0.3% | earnings | Seeking Alpha | Alpha Tau Medical GAAP EPS of -$0.42 |
| 2026-04-23 | -0.3% | legal | MT Newswires | Alpha Tau Expands Alpha Dart Trial Following FDA Approval of IDE Supplement |
| 2026-04-23 | -0.3% | legal | GlobeNewswire | Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel) |
| 2026-04-23 | -0.3% | news | GlobeNewswire | Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial |
| 2026-04-23 | -0.3% | news | Stock Titan | Alpha Tau (NASDAQ: DRTS) advances Alpha DaRT pancreatic cancer clinical trials - Stock Titan |
| 2026-04-23 | -0.3% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | Is Alpha Tau (DRTS) stock trading at a discount | Q4 2025: Profit Exceeds Views - Popular Market Picks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-23 | -0.3% | legal | Stock Titan | Alpha Tau expands pancreatic cancer trial to 40, adds second chemo - Stock Titan |
| 2026-04-23 | -0.3% | news | Stock Titan | A new pancreatic cancer trial in Europe just treated its first patient - Stock Titan |
| 2026-04-08 | -0.2% | news | TradingView | ETFs Investing in Alpha Tau Medical Ltd Stocks - TradingView |